Annual Working Capital
$244.89 M
+$52.54 M+27.32%
December 31, 2023
Summary
- As of February 7, 2025, OLMA annual working capital is $244.89 million, with the most recent change of +$52.54 million (+27.32%) on December 31, 2023.
- During the last 3 years, OLMA annual working capital has fallen by -$92.66 million (-27.45%).
- OLMA annual working capital is now -27.45% below its all-time high of $337.55 million, reached on December 31, 2020.
Performance
OLMA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$187.29 M
-$28.36 M-13.15%
September 30, 2024
Summary
- As of February 7, 2025, OLMA quarterly working capital is $187.29 million, with the most recent change of -$28.36 million (-13.15%) on September 30, 2024.
- Over the past year, OLMA quarterly working capital has dropped by -$78.75 million (-29.60%).
- OLMA quarterly working capital is now -44.51% below its all-time high of $337.55 million, reached on December 31, 2020.
Performance
OLMA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
OLMA Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +27.3% | -29.6% |
3 y3 years | -27.4% | -29.6% |
5 y5 years | +7953.0% | -29.6% |
OLMA Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -13.1% | +27.3% | -33.5% | +19.5% |
5 y | 5-year | -27.4% | >+9999.0% | -44.5% | >+9999.0% |
alltime | all time | -27.4% | >+9999.0% | -44.5% | >+9999.0% |
Olema Pharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $187.29 M(-13.1%) |
Jun 2024 | - | $215.65 M(-4.5%) |
Mar 2024 | - | $225.87 M(-7.8%) |
Dec 2023 | $244.89 M(+27.3%) | $244.89 M(-7.9%) |
Sep 2023 | - | $266.04 M(+69.8%) |
Jun 2023 | - | $156.68 M(-7.8%) |
Mar 2023 | - | $169.99 M(-11.6%) |
Dec 2022 | $192.35 M | $192.35 M(-9.5%) |
Sep 2022 | - | $212.51 M(-7.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $230.72 M(-11.3%) |
Mar 2022 | - | $260.05 M(-7.7%) |
Dec 2021 | $281.67 M(-16.6%) | $281.67 M(-5.9%) |
Sep 2021 | - | $299.38 M(-4.3%) |
Jun 2021 | - | $312.71 M(-3.8%) |
Mar 2021 | - | $324.99 M(-3.7%) |
Dec 2020 | $337.55 M(<-9900.0%) | $337.55 M(+172.6%) |
Sep 2020 | - | $123.81 M(-9810.9%) |
Dec 2019 | -$1.27 M(-141.9%) | -$1.27 M |
Dec 2018 | $3.04 M | - |
FAQ
- What is Olema Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual working capital year-on-year change?
- What is Olema Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly working capital year-on-year change?
What is Olema Pharmaceuticals annual working capital?
The current annual working capital of OLMA is $244.89 M
What is the all time high annual working capital for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual working capital is $337.55 M
What is Olema Pharmaceuticals annual working capital year-on-year change?
Over the past year, OLMA annual working capital has changed by +$52.54 M (+27.32%)
What is Olema Pharmaceuticals quarterly working capital?
The current quarterly working capital of OLMA is $187.29 M
What is the all time high quarterly working capital for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly working capital is $337.55 M
What is Olema Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, OLMA quarterly working capital has changed by -$78.75 M (-29.60%)